Literature DB >> 25606250

Prevalence and determinants of left ventricular hypertrophy in hypertensive patients at a primary care clinic.

Sm Ching, Yc Chia, Wa Wan Azman.   

Abstract

Left ventricular hypertrophy (LVH) has prognostic significance on cardiovascular mortality and morbidity. However, echocardiography screening for LVH is not routinely done for hypertensive patients in a primary care setting. Thus, this quantitative study aims to determine the prevalence and factors associated with LVH in hypertensive patients at a primary care setting. This was a cross-sectional study of 359 consecutive patients with uncomplicated essential hypertension attending a hospital-based clinic in Malaysia. All subjects underwent an echocardiography test. LVH occur when the left ventricular posterior wall thickness together with inter-ventricular septal thickness is ≥11 mm. It was found that 24% patients fulfilled the criteria for LVH. The mean age of the study population was 59.2±7.7 years; mean duration of hypertension was 9.7±7.5 years; and mean blood pressure was 136.5/81.5 (±13.7/7.7) mmHg. Using multiple logistic regression analysis, patients who were obese [odds ratio (OR) 8.34, 95% confidence interval (CI) 3.14, 22.22] and male gender (OR 1.96, 95% CI 1.08, 3.16) had significant positive association with LVH. LVH was found in approximately one fourth of the hypertensive patients at a hospital-based primary care setting. There was a significant positive association between LVH and obesity and being male. Guidelines for enhancing use of echocardiography in detecting LVH may be needed.

Entities:  

Keywords:  Hypertension; Left ventricular; Malaysia; Prevalence; Primary care; hypertrophy

Year:  2012        PMID: 25606250      PMCID: PMC4170431     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  38 in total

1.  Prevalence of left ventricular hypertrophy in a general population; The Tromsø Study.

Authors:  H Schirmer; P Lunde; K Rasmussen
Journal:  Eur Heart J       Date:  1999-03       Impact factor: 29.983

2.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

3.  Cardiovascular disease risk in a semirural community in Malaysia.

Authors:  Chia Yook Chin; Srinivas Pengal
Journal:  Asia Pac J Public Health       Date:  2009-08-05       Impact factor: 1.399

Review 4.  Effects of obesity and subsequent weight reduction on left ventricular function.

Authors:  Mohan Lakhani; Steven Fein
Journal:  Cardiol Rev       Date:  2011 Jan-Feb       Impact factor: 2.644

5.  Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.

Authors:  Vivencio Barrios; Carlos Escobar; Alberto Calderon; Leandre Ribas; David Marti; Enrique Asin
Journal:  Blood Press       Date:  2008       Impact factor: 2.835

6.  Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Bjorn Dahlof
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

Review 7.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.

Authors:  Daniel Pewsner; Peter Jüni; Matthias Egger; Markus Battaglia; Johan Sundström; Lucas M Bachmann
Journal:  BMJ       Date:  2007-08-28

Review 8.  Left ventricular hypertrophy and clinical outcomes in hypertensive patients.

Authors:  Luis M Ruilope; Roland E Schmieder
Journal:  Am J Hypertens       Date:  2008-03-13       Impact factor: 2.689

9.  The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study.

Authors:  M S Lauer; K M Anderson; W B Kannel; D Levy
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

10.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

View more
  2 in total

1.  Left ventricular hypertrophy and proteinuria in patients with essential hypertension in Andkhoy, Afghanistan.

Authors:  Mohammad Shoaib Hamrah; Mohammad Hassan Hamrah; Hideki Ishii; Susumu Suzuki; Mohammad Hussain Hamrah; Ahmad Edris Hamrah; Ahmad Elias Dahi; Maimaiti Yisireyili; Naoaki Kano; Kyosuke Takeshita; Mohammad Hashem Hamrah; Junichi Sakamoto; Toyoaki Murohara
Journal:  Nagoya J Med Sci       Date:  2018-05       Impact factor: 1.131

2.  Rare Copy Number Variants Identified Suggest the Regulating Pathways in Hypertension-Related Left Ventricular Hypertrophy.

Authors:  Hoh Boon-Peng; Julia Ashazila Mat Jusoh; Christian R Marshall; Fadhlina Majid; Norlaila Danuri; Fashieha Basir; Bhooma Thiruvahindrapuram; Stephen W Scherer; Khalid Yusoff
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.